Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LQDA Liquidia Technologies Inc

交易中 04-25 10:38:29 EDT

12.14

-0.41

-3.27%

最高12.50	最低11.80	成交量50.06万
今开12.50	昨收12.55	日振幅5.58%
总市值9.23亿	流通市值6.05亿	总股本7,603万
成交额605.93万	换手率1.00%	流通股本4,984万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":12.14,"timestamp":1714055896395,"preClose":12.55,"halted":0,"volume":500618,"delay":0,"floatShares":49837864,"shares":76027776,"eps":-1.21,"marketStatus":"交易中","marketStatusCode":2,"change":-0.41,"latestTime":"04-25 10:38:29 EDT","open":12.5,"high":12.5,"low":11.8,"amount":6059288.535306,"amplitude":0.055777,"askPrice":12.14,"askSize":10,"bidPrice":12.11,"bidSize":196,"shortable":3,"etf":0,"ttmEps":-1.21,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714075200000},"adr":0,"listingDate":1532577600000,"adjPreClose":12.55,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":12.5,"preClose":12.55,"latestTime":"09:29 EDT","volume":434,"amount":5430.599902,"timestamp":1714051799907},"postHourTrading":{"tag":"盘后","latestPrice":12.37,"preClose":12.55,"latestTime":"19:47 EDT","volume":49247,"amount":617719.55,"timestamp":1714002468001},"volumeRatio":2.77225},"requestUrl":"/m/hq/s/LQDA","defaultTab":"news","newsList":[{"id":"2430286712","title":"Liquidia Corporation盘中异动 股价大跌5.02%报11.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286712","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286712?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:45","pubTimestamp":1714052748,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时45分，Liquidia Corporation股票出现异动，股价快速下挫5.02%。截至发稿，该股报11.92美元/股，成交量16.8775万股，换手率0.22%，振幅4.30%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为1.27%。Liquidia Corporation公司简介：Liquidia Corp 是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足未满足的患者需求，目前的重点是肺动脉高压  和与间质性肺病相关的肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214548861e90cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214548861e90cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426629293","title":"Liquidia Corporation盘中异动 快速上涨5.19%报15.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426629293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426629293?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:31","pubTimestamp":1712863912,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时31分，Liquidia Corporation股票出现异动，股价快速上涨5.19%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.04%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。消息层面，截至03时31分，《Needham：重申Liquidia评级，由买入调整至买入评级, 目标价28.00美元。》资讯为影响Liquidia Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041203315387e7fb02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041203315387e7fb02&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426726469","title":"Needham：重申Liquidia(LQDA.US)评级，由买入调整至买入评级, 目标价28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426726469","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426726469?lang=zh_cn&edition=full","pubTime":"2024-04-10 19:06","pubTimestamp":1712747177,"startTime":"0","endTime":"0","summary":"Needham：重申Liquidia(LQDA.US)评级，由买入调整至买入评级, 目标价28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101906208760adaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101906208760adaf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422799024","title":"Liquidia Corporation盘中异动 早盘急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422799024","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422799024?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:59","pubTimestamp":1711547958,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时59分，Liquidia Corporation股票出现波动，股价快速跳水5.03%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为0.23%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032721591887e7c4e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032721591887e7c4e2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422224245","title":"Liquidia Corporation盘中异动 下午盘股价大跌5.14%报15.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422224245","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422224245?lang=zh_cn&edition=full","pubTime":"2024-03-26 01:51","pubTimestamp":1711389078,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日01时51分，Liquidia Corporation股票出现异动，股价大幅下挫5.14%。截至发稿，该股报15.87美元/股，成交量41.4293万股，换手率0.54%，振幅5.38%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.19%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032601511987e7b8a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032601511987e7b8a7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419185893","title":"Liquidia Corporation盘中异动 下午盘大幅上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419185893","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419185893?lang=zh_cn&edition=full","pubTime":"2024-03-16 02:02","pubTimestamp":1710525733,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日02时02分，Liquidia Corporation股票出现波动，股价急速拉升5.22%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为0.16%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031602021387e7966c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031602021387e7966c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419602700","title":"Liquidia Corporation盘中异动 股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419602700","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419602700?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:41","pubTimestamp":1710423706,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时41分，Liquidia Corporation股票出现波动，股价急速上涨5.30%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.16%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142141477a4cb64a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142141477a4cb64a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419566796","title":"Liquidia Corporation盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419566796","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419566796?lang=zh_cn&edition=full","pubTime":"2024-03-14 02:22","pubTimestamp":1710354179,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日02时22分，Liquidia Corporation股票出现异动，股价快速上涨5.08%。截至发稿，该股报14.69美元/股，成交量49.7574万股，换手率0.66%，振幅8.73%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为0.31%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。其产品包括用于治疗肺动脉高压的YUTREPIA 吸入性粉剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403140222597a4c5ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403140222597a4c5ede&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419844326","title":"Liquidia 公司报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2419844326","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419844326?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:31","pubTimestamp":1710336666,"startTime":"0","endTime":"0","summary":"   * Liquidia Corp   报告了截至12月底的季度调整后每股亏损42美分，低于去年同期的每股收益-9美分。七位分析师对该季度的平均预期是每股亏损 24 美分。华尔街预期为每股-25美分至-22美分。* 收入为 453 万美元，同比下降 15.5%；分析师预期为 473 万美元。* Liquidia Corp 公布的本季度每股收益为亏损 42 美分。* 该公司当季亏损 2745 万美元。华尔街对 Liquidia Corp 的 12 个月目标价中位数为 25.00 美元。本摘要由 LSEG 数据于世界协调时 3 月 13 日下午 01:30 自动生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418316554","title":"Liquidia Corporation盘中异动 股价大涨5.66%报14.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418316554","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418316554?lang=zh_cn&edition=full","pubTime":"2024-03-12 23:26","pubTimestamp":1710257203,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日23时26分，Liquidia Corporation股票出现异动，股价快速上涨5.66%。截至发稿，该股报14.38美元/股，成交量28.777万股，换手率0.38%，振幅4.92%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.99%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。其产品包括用于治疗肺动脉高压的YUTREPIA 吸入性粉剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031223264487e783ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031223264487e783ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418362159","title":"Liquidia Corporation盘中异动 临近午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418362159","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418362159?lang=zh_cn&edition=full","pubTime":"2024-03-11 23:45","pubTimestamp":1710171950,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日23时45分，Liquidia Corporation股票出现异动，股价急速下跌5.06%。截至发稿，该股报13.33美元/股，成交量16.3185万股，换手率0.22%，振幅5.20%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为0.54%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311234550861dd202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311234550861dd202&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418354231","title":"Liquidia Corp   预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2418354231","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418354231?lang=zh_cn&edition=full","pubTime":"2024-03-11 20:57","pubTimestamp":1710161841,"startTime":"0","endTime":"0","summary":"   * Liquidia Corp    将于3月13日公布截至2023年12月31日的季度业绩，预计该公司的季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于北卡罗来纳州莫里斯维尔的公司的营收预计将从去年同期的536万美元下降11.7%，至473.2万美元。* LSEG 分析师对 Liquidia Corp 的平均预期是每股亏损 24 美分。* 华尔街对 Liquidia Corp 的 12 个月目标价中位数为 25.00 美元，高于其最新收盘价 14.04 美元。3月11日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417175946","title":"Liquidia Corporation盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417175946","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417175946?lang=zh_cn&edition=full","pubTime":"2024-03-05 03:06","pubTimestamp":1709579178,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日03时06分，Liquidia Corporation股票出现波动，股价大幅下跌5.10%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为0.17%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305030618791723df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305030618791723df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413644418","title":"更新版 1-United Therapeutics 就竞争对手 Liquidia 的药物申请向 FDA 提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2413644418","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413644418?lang=zh_cn&edition=full","pubTime":"2024-02-21 19:51","pubTimestamp":1708516289,"startTime":"0","endTime":"0","summary":"     路透社2月21日 - United Therapeutics   周三表示，它已向美国食品及药物管理局提起诉讼，指控该局在批准竞争对手Liquidia Corp   的降压药申请时没有遵循正当程序。United Therapeutics声称，Liquidia公司在申请一种吸入式曲普瑞替尼干粉，用于治疗间质性肺病引起的肺动脉高压 时，规避了FDA的长期规则、先例和程序。United Therapeutics 还起诉 Liquidia 侵犯了其药物 Tyvaso 的专利权。Liquidia公司上月表示， ，FDA仍在对其药物进行审查，审查决定将于1月24日做出。FDA和Liquidia没有立即回应路透社的置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412106729","title":"Liquidia Corporation盘中异动 早盘股价大跌6.99%报13.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2412106729","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412106729?lang=zh_cn&edition=full","pubTime":"2024-02-20 23:07","pubTimestamp":1708441672,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日23时07分，Liquidia Corporation股票出现异动，股价大幅下跌6.99%。截至发稿，该股报13.57美元/股，成交量15.4516万股，换手率0.20%，振幅3.63%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.17%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402202307537a450277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402202307537a450277&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411798395","title":"Liquidia Corporation盘中异动 下午盘大幅下挫5.11%报14.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411798395","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411798395?lang=zh_cn&edition=full","pubTime":"2024-02-14 02:53","pubTimestamp":1707850423,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日02时53分，Liquidia Corporation股票出现波动，股价急速下挫5.11%。截至发稿，该股报14.29美元/股，成交量46.0417万股，换手率0.61%，振幅5.18%。Liquidia Corporation股票所在的生物技术行业中，整体跌幅为1.03%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214025343861d51ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214025343861d51ce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409207772","title":"Liquidia Corporation盘中异动 急速上涨5.02%报14.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409207772","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409207772?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:56","pubTimestamp":1707317808,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日22时56分，Liquidia Corporation股票出现波动，股价快速拉升5.02%。截至发稿，该股报14.22美元/股，成交量37.4759万股，换手率0.49%，振幅5.76%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.53%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722564879101195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722564879101195&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408663858","title":"Liquidia Corporation盘中异动 下午盘大幅上涨5.01%报13.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408663858","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408663858?lang=zh_cn&edition=full","pubTime":"2024-02-02 02:51","pubTimestamp":1706813462,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日02时51分，Liquidia Corporation股票出现波动，股价急速上涨5.01%。截至发稿，该股报13.42美元/股，成交量29.0739万股，换手率0.38%，振幅5.95%。Liquidia Corporation股票所在的生物技术行业中，整体涨幅为0.93%。Liquidia Corporation公司简介：Liquidia Corp是一家总部位于美国的生物制药公司，专注于开发、制造和商业化产品，以满足患者未满足的需求，目前的重点是肺动脉高压的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202025103790e44d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202025103790e44d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406299937","title":"BUZZ-Liquidia 因 FDA 继续审查其肺动脉高压药物而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2406299937","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406299937?lang=zh_cn&edition=full","pubTime":"2024-01-25 19:49","pubTimestamp":1706183392,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月25日 - ** Liquidia  股价盘前下跌10.5%至10.79美元 ** 该公司称 (link)，美国FDA仍在审查其治疗肺动脉高压伴间质性肺病的药物(PH-ILD)** PH-ILD 是一种与肺部疾病相关的进行性血管疾病。** 美国 FDA 没有要求提供更多的临床数据来支持该申请** 截至周三收盘，股价在过去 12 个月中上涨了 74.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406479295","title":"更新版 1-美国 FDA 仍在审查 Liquidia 的吸入式降压药","url":"https://stock-news.laohu8.com/highlight/detail?id=2406479295","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406479295?lang=zh_cn&edition=full","pubTime":"2024-01-25 19:25","pubTimestamp":1706181909,"startTime":"0","endTime":"0","summary":"     路透1月25日 - 美国食品和药物管理局仍在审查Liquidia公司的  药物，该药物用于治疗一种与肺部疾病有关的进行性血管紊乱，该公司周四表示。美国食品和药物管理局预计将在本周三做出决定，但它仍在审查Liquidia的上市申请，尽管它没有要求提供 更多的临床数据来支持该申请。该药物于2021年获得暂定批准，用于治疗肺动脉高压，以提高成年患者的运动能力。然而，由于与United Therapeutics   公司的专利侵权纠纷，Liquidia公司无法在美国销售该药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":-0.0945},{"period":"1month","weight":-0.1991},{"period":"3month","weight":0.0485},{"period":"6month","weight":1.0242},{"period":"1year","weight":0.8731},{"period":"ytd","weight":0.0432}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造，PRINT技术是一种粒子工程平台，能够精确生产均匀的药物颗粒，旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究，该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验，包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.035484},{"month":2,"riseRate":0.833333,"avgChangeRate":0.087008},{"month":3,"riseRate":0.5,"avgChangeRate":-0.044367},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.078612},{"month":5,"riseRate":0.8,"avgChangeRate":0.183181},{"month":6,"riseRate":0.2,"avgChangeRate":-0.05846},{"month":7,"riseRate":0.2,"avgChangeRate":-0.103369},{"month":8,"riseRate":0.5,"avgChangeRate":0.018003},{"month":9,"riseRate":0.333333,"avgChangeRate":0.087548},{"month":10,"riseRate":0.5,"avgChangeRate":0.008487},{"month":11,"riseRate":0.666667,"avgChangeRate":0.032537},{"month":12,"riseRate":0.666667,"avgChangeRate":0.188565}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}